Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLAU | P00749 | 8/20 | 0.45 |
| ▸ | PLG | P00747 | 7/20 | 0.45 |
| ▸ | F2 | P00734 | 7/20 | 0.45 |
| ▸ | PRSS1 | P07477 | 6/20 | 0.45 |
| ▸ | PLAT | P00750 | 6/20 | 0.45 |
| ▸ | KLKB1 | P03952 | 5/20 | 0.45 |
| ▸ | KLK1 | P06870 | 3/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | PRMT1 | Q99873 | 2/20 | 0.40 |
| ▸ | CNR2 | P34972 | 1/20 | 0.40 |
| ▸ | SETD7 | Q8WTS6 | 1/20 | 0.40 |
| ▸ | F10 | P00742 | 5/20 | 0.40 |
| ▸ | KLK5 | Q9Y337 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25017838 | 0.92 | PLAU (0.44) | PLAUPLGF2PRSS1PLAT | |
| SCHEMBL25016097 | 0.90 | F2 (0.42) | PLAUPLGF2PRSS1PLAT | |
| SCHEMBL25017840 | 0.88 | NPC1 (0.46) | PLAUPLGF2PRSS1PLAT | |
| SCHEMBL25017313 | 0.87 | PLAU (0.43) | PLAUPLGF2PRSS1PLAT | |
| SCHEMBL21822422 | 0.85 | ALDH1A1 (0.44) | PLAUPLGF2PRSS1PLAT | |
| SCHEMBL25017925 | 0.80 | F10 (0.43) | PLAUPLGF2PRSS1PLAT | |
| SCHEMBL25016759 | 0.79 | F2 (0.42) | PLGF2PRSS1ALDH1A1CNR2 | |
| SCHEMBL25016737 | 0.79 | PRSS1 (0.45) | F2PRSS1F10 | |
| SCHEMBL25016131 | 0.79 | PRSS1 (0.45) | F2PRSS1F10 | |
| SCHEMBL25015665 | 0.78 | PLAU (0.52) | PLAUPLGF2PRSS1PLAT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230043159-A1 | MATRIPTASE 2 INHIBITORS AND USES THEREOF | DISC MEDICINE, INC. | 2023-02-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230043159-A1 | MATRIPTASE 2 INHIBITORS AND USES THEREOF | MMP7, MATR3, SPINT2 | PLAU 93/4885PLG 225/4885F2 408/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.